Savara Inc. (NASDAQ:SVRA) is one of the top long-term biotechnology stocks to buy. On October 2, Savara Inc. (NASDAQ:SVRA) announced that its partner, TrilliumBiO, will present data on the development of a dried-serum assay at the upcoming CHEST 2025 conference. Savara Inc. (SVRA) To Present Molgramostim Data in the Fight Against Infections Copyright: djoronimo / 123RF Stock Photo TrilliumBiO is developing a dried-serum assay to enhance the detection of GM-CSF antibodies and aid in diagnosing autoimmune ...